Plasma Cell Myeloma Recurrent
1 clinical trials · Condition
◉ Watch Plasma Cell Myeloma Recurrent
| Record | Firm | Date |
|---|---|---|
| SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM (NCT05405166) | Sanofi | 2022-06-23 |
Track Plasma Cell Myeloma Recurrent automatically
Every clearance here is in the API, with alerts when new ones post.